Open access. The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting.
Open access. The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting.
Open access. The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting.
The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting. To read the full article, log in using your NHS OpenAthens details.
This patient group direction (PGD) template supports the administration of BCG Vaccine AJV, to individuals from birth to 16 years of age, at increased risk of tuberculosis in accordance with the national selective immunisation programme and recommendations given in Chapter 32 of Immunisation Against Infectious Disease: The Green Book.
This template letter can be used by provider organisations when communicating to parents of babies who have missed BCG immunisation. It may be adapted for local needs, although PHE suggest the main body of the text remains unchanged.
This poster is aimed at healthcare professionals administering the Bacillus Calmette-Guérin (BCG) vaccine in all healthcare and pharmacy settings.
Please download, print it and display it close to the vaccine fridge and preparation area prominently.